149 related articles for article (PubMed ID: 30956977)
41. Neuroleptic-resistant schizophrenic patients treated by clozapine: clinical evolution, plasma and red blood cell clozapine and desmethylclozapine levels.
Aymard N; Baldacci C; Leyris A; Smagghe PO; Tribolet S; Vacheron MN; Viala A; Caroli F
Therapie; 1997; 52(3):227-32. PubMed ID: 9366107
[TBL] [Abstract][Full Text] [Related]
42. Quantification of the steady-state plasma concentrations of clozapine and N-desmethylclozapine in Japanese patients with schizophrenia using a novel HPLC method and the effects of CYPs and ABC transporters polymorphisms.
Akamine Y; Sugawara-Kikuchi Y; Uno T; Shimizu T; Miura M
Ann Clin Biochem; 2017 Nov; 54(6):677-685. PubMed ID: 27932669
[TBL] [Abstract][Full Text] [Related]
43. A population pharmacokinetic model to guide clozapine dose selection, based on age, sex, ethnicity, body weight and smoking status.
Reeves S; Bertrand J; Obee SJ; Hunter S; Howard R; Flanagan RJ
Br J Clin Pharmacol; 2024 Jan; 90(1):135-145. PubMed ID: 36793249
[TBL] [Abstract][Full Text] [Related]
44. Serum concentrations of clozapine and norclozapine in the prediction of relapse of patients with schizophrenia.
Xiang YQ; Zhang ZJ; Weng YZ; Zhai YM; Li WB; Cai ZJ; Tan QR; Wang CY
Schizophr Res; 2006 Apr; 83(2-3):201-10. PubMed ID: 16524698
[TBL] [Abstract][Full Text] [Related]
45. Plasma clozapine concentration coefficients of variation in a long-term study.
Diaz FJ; de Leon J; Josiassen RC; Cooper TB; Simpson GM
Schizophr Res; 2005 Jan; 72(2-3):131-5. PubMed ID: 15560958
[TBL] [Abstract][Full Text] [Related]
46. Microdialysis evaluation of clozapine and N-desmethylclozapine pharmacokinetics in rat brain.
Cremers TI; Flik G; Hofland C; Stratford RE
Drug Metab Dispos; 2012 Oct; 40(10):1909-16. PubMed ID: 22736307
[TBL] [Abstract][Full Text] [Related]
47. Generic lamotrigine versus brand-name Lamictal bioequivalence in patients with epilepsy: A field test of the FDA bioequivalence standard.
Ting TY; Jiang W; Lionberger R; Wong J; Jones JW; Kane MA; Krumholz A; Temple R; Polli JE
Epilepsia; 2015 Sep; 56(9):1415-24. PubMed ID: 26201987
[TBL] [Abstract][Full Text] [Related]
48. Generic clozapine: a cost-saving alternative to brand name clozapine?
Tse G; Thompson D; Procyshyn RM
Pharmacoeconomics; 2003; 21(1):1-11. PubMed ID: 12484800
[TBL] [Abstract][Full Text] [Related]
49. Potential Role of Patients' CYP3A-Status in Clozapine Pharmacokinetics.
Tóth K; Csukly G; Sirok D; Belic A; Kiss Á; Háfra E; Déri M; Menus Á; Bitter I; Monostory K
Int J Neuropsychopharmacol; 2017 Jul; 20(7):529-537. PubMed ID: 28340122
[TBL] [Abstract][Full Text] [Related]
50. The effect of variable cigarette consumption on the interaction with clozapine and olanzapine.
Haslemo T; Eikeseth PH; Tanum L; Molden E; Refsum H
Eur J Clin Pharmacol; 2006 Dec; 62(12):1049-53. PubMed ID: 17089108
[TBL] [Abstract][Full Text] [Related]
51. Reduction of clozapine-induced hypersalivation by pirenzepine is safe.
Schneider B; Weigmann H; Hiemke C; Weber B; Fritze J
Pharmacopsychiatry; 2004 Mar; 37(2):43-5. PubMed ID: 15048609
[TBL] [Abstract][Full Text] [Related]
52. Determination of clozapine, norclozapine, and clozapine-N-oxide in serum by liquid chromatography.
Volpicelli SA; Centorrino F; Puopolo PR; Kando J; Frankenburg FR; Baldessarini RJ; Flood JG
Clin Chem; 1993 Aug; 39(8):1656-9. PubMed ID: 8353952
[TBL] [Abstract][Full Text] [Related]
53. Pharmacokinetic Evaluation of Clozapine in Concomitant Use of Radix Rehmanniae, Fructus Schisandrae, Radix Bupleuri, or Fructus Gardeniae in Rats.
Tian DD; Wang W; Wang HN; Sze SC; Zhang ZJ
Molecules; 2016 May; 21(6):. PubMed ID: 27240333
[TBL] [Abstract][Full Text] [Related]
54. Measurement of Clozapine, Norclozapine, and Amisulpride in Plasma and in Oral Fluid Obtained Using 2 Different Sampling Systems.
Fisher DS; Beyer C; van Schalkwyk G; Seedat S; Flanagan RJ
Ther Drug Monit; 2017 Apr; 39(2):109-117. PubMed ID: 28125503
[TBL] [Abstract][Full Text] [Related]
55. Evaluation of three dosing models for the prediction of steady-state trough clozapine concentrations.
Paz E; Bouzas L; Hermida J; Brenlla J; Tutor JC
Clin Biochem; 2008 May; 41(7-8):603-6. PubMed ID: 18280253
[TBL] [Abstract][Full Text] [Related]
56. Towards Precision Dosing of Clozapine in Schizophrenia: External Evaluation of Population Pharmacokinetic Models and Bayesian Forecasting.
Lereclus A; Korchia T; Riff C; Dayan F; Blin O; Benito S; Guilhaumou R
Ther Drug Monit; 2022 Oct; 44(5):674-682. PubMed ID: 35385439
[TBL] [Abstract][Full Text] [Related]
57. Prescribing and monitoring clozapine in Christchurch.
McKean A; Vella-Brincat J; Begg E
Australas Psychiatry; 2008 Aug; 16(4):263-7. PubMed ID: 18668375
[TBL] [Abstract][Full Text] [Related]
58. Impact of tobacco smoking cessation on stable clozapine or olanzapine treatment.
Lowe EJ; Ackman ML
Ann Pharmacother; 2010 Apr; 44(4):727-32. PubMed ID: 20233914
[TBL] [Abstract][Full Text] [Related]
59. Pharmacokinetics of clozapine and its metabolites in hippocampal HT22 cells.
Heiser P; Schüler-Springorum M; Schulte E; Hausmann C; Remschmidt H; Krieg JC; Vedder H
Eur J Pharmacol; 2003 Aug; 476(3):167-72. PubMed ID: 12969762
[TBL] [Abstract][Full Text] [Related]
60. A comprehensive review of the clinical utility of and a combined analysis of the clozapine/norclozapine ratio in therapeutic drug monitoring for adult patients.
Schoretsanitis G; Kane JM; Ruan CJ; Spina E; Hiemke C; de Leon J
Expert Rev Clin Pharmacol; 2019 Jul; 12(7):603-621. PubMed ID: 31075044
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
